Willingness to pay for cancer genetic testing in a tertiary healthcare centre

Azimatun Noor Aizuddin and Syed Rusli SAS and Abdul Rahman Ramdzan and Sharifah Azween Syed Omar and Zuria Mahmud and Zarina Abdul Latiff and Shamsul Azhar Shah and Salleh Amat and Fuad Ismail and Keng, Wee Teik and Ch Ng, Gaik Siew and Haniza Rais and Syed Mohamed Aljunid (2021) Willingness to pay for cancer genetic testing in a tertiary healthcare centre. International Medical Journal Malaysia, 20 (3). pp. 5-12. ISSN 1823-4631

	Text Willingness to pay for cancer genetic testing in a tertiary healthcare centre-Abstract.pdf Download (62kB)
	Text Willingness to Pay for Cancer Genetic Testing in a Tertiary Healthcare Centre.pdf Restricted to Registered users only Download (1MB) | Request a copy

Abstract

Increasing use of predictive genetic testing to address hereditary cancer risk has been commonly assessed by cost sharing practices. Little is known about how demographics, knowledge, attitude and practices may influence these individuals’ willingness to pay for cancer genetic testing. The objective of this research was to determine factors associated with willingness to pay for cancer genetic testing. A self-administered questionnaire was distributed to 175 respondents in the oncology and day care unit in one of tertiary healthcare centre. The respondents comprised cancer patients, their family members and the community. A total of 117 (66.9%) participants were willing to pay for cancer genetic testing. Ninety three (79.5%) of respondents were willing to pay from their own pocket with a mean of MYR1201.77 (SD976.72) and 95 (54.3%) respondents were willing to pay, shared with insurance. There were significant associations between willingness to pay with status of respondent as patients or family members or community, gender, race, educational level, income, knowledge and attitude. This is the first study to evaluate factors associated with willingness to pay not only among cancer patients but also their family members and the community. These findings reveal that majority of respondents believe there is valuable personal benefit based on genetic risk information and they are willing to pay for it.

Item Type:	Article
Keyword:	Willingness to pay , Genetic testing , Cancer , Genetic
Subjects:	H Social Sciences > HT Communities. Classes. Races > HT51-1595 Communities. Classes. Races R Medicine > RC Internal medicine > RC31-1245 Internal medicine > RC254-282 Neoplasms. Tumors. Oncology Including cancer and carcinogens
Department:	FACULTY > Faculty of Medicine and Health Sciences
Depositing User:	DG MASNIAH AHMAD -
Date Deposited:	25 Oct 2021 19:29
Last Modified:	25 Oct 2021 19:29
URI:	https://eprints.ums.edu.my/id/eprint/30611

Actions (login required)

View Item